Cell MedX Corp. Closes Private Placement Financing
Vancouver, British Columbia--(Newsfile Corp. - March 19, 2024) - Cell MedX Corp. (OTC Pink: CMXC) ("Cell MedX", or the "Company") a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote anti-aging and general wellness, announces that it has closed a non-brokered private placement offering (the "Offering") by issuing 2,500,000 units (each a "Unit") at US$0.03 per Unit for total gross proceeds of US$75,000. Each...
2024-03-19 1:28 PM EDT
Cell MedX Corp. Announces Resignation of Director
Vancouver, British Columbia--(Newsfile Corp. - February 28, 2024) - Cell MedX Corp. (OTC Pink: CMXC) ("Cell MedX", or the "Company") a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote anti-aging and general wellness, announces the resignation of Brad Hargreaves from the Board of Directors of the Company. The resignation of Mr. Hargreaves was not due to any disagreement with the Company on any matter relating...
2024-02-28 4:47 PM EST
Cell MedX Corp. Appoints Dr. George Adams as Chairman of the Board
Vancouver, British Columbia--(Newsfile Corp. - February 26, 2024) - Cell MedX Corp. (OTC Pink: CMXC) ("Cell MedX", or the "Company") a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote anti-aging and general wellness, is pleased to announce the appointment by the board of directors of Dr. George Adams as Chairman of the Board.Dr. Adams has served on the board of directors of the Company since March 23, 2018...
2024-02-26 9:15 AM EST
Cell MedX Corp. Announces New CEO and Directors and Debt Settlement
Vancouver, British Columbia--(Newsfile Corp. - December 19, 2023) - Cell MedX Corp. (OTC Pink: CMXC) ("Cell MedX" or the "Company"), a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness, announces that Mr. Dwayne Yaretz has resigned as Chief Executive Officer of the Company and Mr. Brad Hargreaves has resigned as VP of Technology and Operations. Mr. David Jeffs has been appointed as the new...
2023-12-19 2:24 PM EST
Cell MedX Corp. Announces Full Revocation of British Columbia Cease Trade Order
Vancouver, British Columbia--(Newsfile Corp. - November 27, 2023) - Cell MedX Corp. ("Cell MedX" or the "Company") (OTC Pink: CMXC) announces that on November 22, 2023, the British Columbia Securities Commission (the "BCSC") issued an order revoking the Cease Trade Order previously issued by the Commission on October 11, 2022 (the "CTO"). The CTO was previously issued by the BCSC for Cell MedX failing to file audited financial statements and related management's discussion and analysis and an...
2023-11-27 1:16 PM EST
Cell MedX Corp. Appoints Audit Committee and Accepts Resignation of Chief Operating Officer
Vancouver, British Columbia--(Newsfile Corp. - November 9, 2023) - Cell MedX Corp. (OTC Pink: CMXC) ("Cell MedX" or the "Company"), a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness, is pleased to announce that it has appointed Mr. Dwayne Yaretz, Mr. George Adams and Mr. Joao (John) da Costa as members of the Company's Audit Committee.The Company also announces that Mr. Joao da Costa has...
2023-11-09 8:00 AM EST
Cell MedX Amends Loan Agreements, Provides Update on Financing and Regulatory Compliance
Carson City, Nevada--(Newsfile Corp. - October 18, 2022) - Cell MedX Corp. (OTC Pink: CMXC) ("Cell MedX" or the "Company"), a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness, has amended terms of its loans with Richard Jeffs, the Company's major shareholder and largest financier.The Company's current operations are centered around further development of its eBalance® Home and Pro Systems,...
2022-10-18 5:03 PM EDT
FDA Submission and Corporate Update
Carson City, Nevada--(Newsfile Corp. - September 20, 2022) - Cell MedX Corp. (OTC PINK: CMXC) ("Cell MedX" or the "Company"), a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness, is providing the following corporate update including the U.S. Food and Drug Administration (FDA) premarket notification (510(k)) submission.FDA Premarket Notification (510(k)) Update; In September 2021, Cell MedX...
2022-09-20 8:30 AM EDT
Cell MedX Corp: Letter to Shareholders from Mr. Dwayne Yaretz, CEO
Carson City, Nevada--(Newsfile Corp. - June 27, 2022) - Cell MedX Corp. (OTCQB: CMXC) ("Cell MedX" or the "Company"), a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness, is pleased to issue the following letter from Mr. Dwayne Yaretz the Company's new CEO.Mr. Yaretz, CEO;Having recently accepted the positions of CEO and Director of Cell MedX, I wanted to introduce myself to you, highlight the...
2022-06-27 8:00 AM EDT
Cell MedX Corp. Appoints Mr. Dwayne Yaretz as CEO and Director
Carson City, Nevada--(Newsfile Corp. - April 27, 2022) - Cell MedX Corp. (OTCQB: CMXC) ("Cell MedX" or the "Company"), a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness, is pleased to announce that it has appointed Mr. Dwayne Yaretz to the Board of Directors and as Chief Executive Officer. Mr. Yaretz replaces Mr. McEnulty, as CEO of the Company. Mr. McEnulty will continue to serve as a...
2022-04-27 9:00 AM EDT
Cell MedX Corp. to Attend the 29th Annual Wellness Show 2022 Held in Vancouver, BC
Carson City, Nevada--(Newsfile Corp. - March 24, 2022) - Cell MedX Corp. (OTCQB: CMXC) ("Cell MedX" or the "Company"), a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness, is pleased to announce that it will be participating as an exhibitor at the 29th Annual Wellness Show held at Vancouver Convention Centre, East Building, on March 26th - 27th. The Wellness Show is a host of Western Canada's...
2022-03-24 8:00 AM EDT
FDA Commences Review of Cell MedX's Premarket Notification (510K) and Health Canada Renews Class II Medical Device Licenses for eBalance(R) Systems
Carson City, Nevada--(Newsfile Corp. - November 15, 2021) - Cell MedX Corp. (OTCQB: CMXC) ("Cell MedX" or the "Company"), a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness, is pleased to announce that the U.S. Food and Drug Administration (FDA) has acknowledged the receipt of the premarket notification (510K) for the eBalance® Home System and eBalance® Pro System. The submission is in the...
2021-11-15 8:30 AM EST
Cell MedX Corp. Files Premarket Notification (510K) with the US Food and Drug Administration and Receives Canadian Trademark
Carson City, Nevada--(Newsfile Corp. - September 17, 2021) - Cell MedX Corp. (OTCQB: CMXC) ("Cell MedX" or the "Company"), a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness, is pleased to announce that it has submitted a premarket notification (510K) to the U.S. Food and Drug Administration (FDA) for the eBalance® Home System and eBalance® Pro System.The eBalance® Pro System and eBalance®...
2021-09-17 9:00 AM EDT
Cell MedX Corp. Converts Debt to Shares, Closes Non-Brokered Private Placement Financing, and Engages Investor Relations Consultants
Carson City, Nevada--(Newsfile Corp. - May 26, 2021) - Cell MedX Corp. (OTCQB: CMXC) ("Cell MedX" or the "Company"), a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general health and wellness, is pleased to announce that on May 25, 2021, the Company issued 2,484,500 common shares of the Company (the "Shares") on conversion of $496,900 the Company owed its debt holders under 6% demand notes payable and...
2021-05-26 8:00 AM EDT
Cell MedX Corp. Signs Extension Agreement with Think Ink Marketing
Carson City, Nevada--(Newsfile Corp. - September 24, 2020) - Cell MedX Corp. (OTCQB: CMXC), Cell MedX Corp. ("Cell MedX" or the "Company"), a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general health and wellness, announced today that it has signed an extension agreement with Think Ink Marketing Data & Email Services, Inc. ("Think Ink") to provide public relations services in an effort to increase...
2020-09-24 8:00 AM EDT
Cell MedX Corp.'s eBalance Pro System Receives Class II Medical Device License from Health Canada
Carson City, Nevada--(Newsfile Corp. - September 1, 2020) - Cell MedX Corp. (OTCQB: CMXC), ("Cell MedX" or the "Company"), a bio-tech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general health and wellness, is happy to announce that in August 2020, Health Canada granted Cell MedX (Canada) Corp., the Company's wholly-owned subsidiary, a Class II Medical Device License for its innovative eBalance Pro System. The...
2020-09-01 10:57 AM EDT
Cell MedX Corp. Closes Non-Brokered Private Placement Financing
Carson City, Nevada--(Newsfile Corp. - August 4, 2020) - Cell MedX Corp. (OTCQB: CMXC), ("Cell MedX" or the "Company"), a bio-tech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general health and wellness, is pleased to announce that on July 30, 2020, the Company closed its non-brokered private placement offering (the "Offering") at a price of $0.25 per unit (the "Unit"), by issuing 988,000 Units for total gross...
2020-08-04 8:00 AM EDT
Cell MedX Corp.'s eBalance Home System Receives Class II Medical Device License from Health Canada
Carson City, Nevada--(Newsfile Corp. - July 22, 2020) - Cell MedX Corp. (OTCQB: CMXC) ("Cell MedX" or the "Company"), a bio-tech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general health and wellness, is happy to announce that on July 17, 2020, Health Canada granted Cell MedX (Canada) Corp., the Company's wholly-owned subsidiary, a Class II Medical Device License for its innovative eBalance Home System. The...
2020-07-22 8:00 AM EDT
Cell MedX Corp. Files Two Applications for Class II Medical Device Licenses with Health Canada
Carson City, Nevada--(Newsfile Corp. - July 7, 2020) - Cell MedX Corp. (OTCQB: CMXC) ("Cell MedX" or the "Company"), a bio-tech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness, announced today that the Company has filed an application for a Class II Medical Device License for the eBalance Pro System and the eBalance Home System with Health Canada. The applications consisted of the Device License...
2020-07-07 8:00 AM EDT
Cell MedX Corp. Receives Quality Management System ISO 13485:2016 MDSAP Certificate
Carson City, Nevada--(Newsfile Corp. - June 9, 2020) - Cell MedX Corp. (OTCQB: CMXC) ("Cell MedX" or the "Company"), a bio-tech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness, announced today that the Company received a Quality Management System - ISO 13485:2016 certificate #MDSAP 716274 for design, development, and manufacture of microcurrent therapeutic devices, specifically the Company's...
2020-06-09 8:00 AM EDT